bIo-mEdTech.com
About bIo-mEdTech.com
Bio-Med Technologies, a biopharmaceutical company with headquarters in Ghent, Belgium, is engaged in the discovery and development of Nanobodies to treat a range of serious human diseases. Nanobodies are a novel class of antibody-derived therapeutic proteins. Because of their small size, unique structure and extreme stability, Nanobodies combine the advantages of conventional antibody therapeutics with the key features of small-molecule drugs.
